Aquaculture Vaccines Market Scope And Analysis

Aquaculture Vaccines Market Report Scope

 Aquaculture Vaccines Market News and Recent Developments

The aquaculture vaccines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the aquaculture vaccines market are listed below:

• Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., announced that it had signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for US$ 1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutrition and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions. (Source: Merck Animal Health, Press Release, February 2024)

Aquaculture Vaccines Market Report Coverage and Deliverables

The “Aquaculture Vaccines Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Aquaculture vaccines market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Aquaculture vaccines market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Aquaculture vaccines market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the aquaculture vaccines market
• Detailed company profiles